[
    {
        "file_name": "ANIXABIOSCIENCESINC_06_09_2020-EX-10.1-COLLABORATION AGREEMENT.txt",
        "perturbation": [
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "This Collaboration Agreement (the \"Agreement\") is made as of April 14th, 2020 (the \"Effective Date\") by and between Anixa Biosciences, Inc., a Delaware corporation, located at 3150 Almaden Expressway, Suite 250, San Jose, CA 95118, U.S.A. (\"Anixa\"), and OntoChem GmbH, a German limited liability company, located at Blücherstr. 24, D-06120 Halle (Saale), Germany (\"OntoChem\"). Anixa and OntoChem are referred to herein individually as a \"Party\" and collectively as the \"Parties.\"",
                "changed_text": "This Collaboration Agreement (the \"Agreement\") is made as of April 14th, 2020 (the \"Effective Date\") by and between Anixa Biosciences, Inc., a Delaware corporation, located at 3150 Almaden Expressway, Suite 250, San Jose, CA 95118, U.S.A. (\"Anixa\"), and OntoChem GmbH, a German limited liability company, located at Blücherstr. 24, D-06120 Halle (Saale), Germany (\"Vendor\"). Anixa and OntoChem are referred to herein individually as a \"Party\" and collectively as the \"Parties.\"",
                "explanation": "The term 'OntoChem' is replaced with 'Vendor' in the introductory paragraph. This creates ambiguity because later sections still refer to 'OntoChem,' potentially leading to confusion about whether both terms refer to the same entity or whether 'Vendor' has specific obligations distinct from OntoChem.",
                "location": "Preamble"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "8.2 Indemnification by OntoChem. OntoChem will indemnify, defend and hold harmless Anixa, its Affiliates and their respective Representatives from and against any liability, demand, damage, cost or expense (including reasonable attorney's fees) arising from any third-party claim, action or proceeding arising from (a) OntoChem's breach of this Agreement or (b) OntoChem's negligence or willful misconduct in connection with this Agreement, except with respect to any matter for which Anixa is obligated to provide indemnification under Section 8.1. Financial reimbursements claimed according to such indemnification shall not exceed payments received by OntoChem under this contract.",
                "changed_text": "8.2 Indemnification by OntoChem. The Supplier will indemnify, defend and hold harmless Anixa, its Affiliates and their respective Representatives from and against any liability, demand, damage, cost or expense (including reasonable attorney's fees) arising from any third-party claim, action or proceeding arising from (a) the Supplier's breach of this Agreement or (b) the Supplier's negligence or willful misconduct in connection with this Agreement, except with respect to any matter for which Anixa is obligated to provide indemnification under Section 8.1. Financial reimbursements claimed according to such indemnification shall not exceed payments received by OntoChem under this contract.",
                "explanation": "The term 'OntoChem' is replaced with 'the Supplier' in the first half of the section. This creates ambiguity about whether 'OntoChem' and 'the Supplier' are the same. The last line still mentions the term 'OntoChem,' further illustrating the confusion regarding the indemnifying party's financial responsibility and potentially creating a contradiction in obligations if they're not interpreted as the same entity.",
                "location": "Section 8.2"
            },
            {
                "type": "Misaligned Terminology - In Text Contradiction",
                "original_text": "3.  Financial Terms.\n\n3.1 Research Program Payments. In consideration for OntoChem's performance of its activities under the Research Plan, Anixa will:\n\n(a) pay OntoChem 100,002 Euros in six (6) equal installments as follows: (i) 16,667 Euros within five (5) days after the Effective Date; and (ii) five (5) installments in the amount of 16,667 Euros on each one-month anniversary of the Effective Date, except that the last such payment will be due within thirty (30) days after completion of all activities under the Research Plan; and",
                "changed_text": "3.  Financial Terms.\n\n3.1 Research Program Payments. In consideration for the Contractor's performance of its activities under the Research Plan, Anixa will:\n\n(a) pay OntoChem 100,002 Euros in six (6) equal installments as follows: (i) 16,667 Euros within five (5) days after the Effective Date; and (ii) five (5) installments in the amount of 16,667 Euros on each one-month anniversary of the Effective Date, except that the last such payment will be due within thirty (30) days after completion of all activities under the Research Plan; and",
                "explanation": "The term 'OntoChem's' is replaced with 'the Contractor's' in the beginning of the section. This creates ambiguity about whether 'OntoChem' and 'the Contractor' are the same. The installment payments will still be paid to 'OntoChem,' so it becomes unclear whether 'the Contractor' is different from OntoChem, leading to confusion about to whom obligations are owed.",
                "location": "Section 3.1"
            }
        ]
    }
]